Large language model (LLM)-based AI Scientists advance scientific discovery, yet they suffer from inefficiencies due to noisy observations. Existing principle-evolving agents act on every anomaly, leaving its source unresolved: a new mechanism or an evaluation artifact, so invalid revisions bias evolution. To address this, we formulate revision as evidence admission: anomalies steer search immediately, but only independently verified evidence may rewrite persistent principles, and contradicted principles are retracted. We realize this in TRIAGE-PIEVO , which pairs an anomaly-responsive search portfolio with a staged verification gate that alone controls what enters principle state. Across four scientific tasks with three backbones, TRIAGE-PIEVO (1) attains the highest average solution quality with +7.5%~11.8% over the strongest baseline per backbone, matching the strongest baseline's full-budget quality with one-third of the evaluation budget on Qwen3-235B; and additional stress tests and cross-harness deployment demonstrate that (2) in constructed stress tests, it admits none of the corrupted, hidden-source, or exploit evidence that ungated variants admit, while missing no planted mechanism, and (3) plugged unchanged into three external research harnesses, it cuts false evidence admissions by over 60% and raises verified scores by 31%~43%.
Figure 2: Overview of Triage-PiEvo . Left: an outcome-blind AFE portfolio cycles candidate proposals across exploitation, frontier expansion, and mechanism-discriminating probes. Middle: Triage treats an anomalous residual as source-ambiguous and routes it to quarantine, search history, or verification rather than attributing it to a source at runtime. Right: principles advance Proposed → Provisional → Accepted only with independent held-out support; contradictory evidence retracts them.
Figure 3: AFE portfolio schematic. Three complementary roles on a shared design manifold: exploitation ( ↑μ^ ), frontier expansion ( ↑N,D ), and mechanism probes ( ↑σ^ ).
Model / Method
MBO
NHO
SPO
TMC
Average
Qwen3-235B (No Thinking)
Vanilla MAS
83.35 ± 29.95
52.83 ± 20.36
37.29 ± 0.75
56.34 ± 3.69
57.45
ReAct
75.48 ± 4.94 ↓ 0.9x
61.95 ± 17.08 ↑ 1.2x
37.49 ± 0.46
72.80 ± 4.48 ↑ 1.3x
61.93 ↑ 1.1x
AI Scientist v1
73.37 ± 39.82 ↓ 0.9x
41.50 ± 3.12 ↓ 0.8x
37.04 ± 0.61
63.96 ± 8.93 ↑ 1.1x
53.97 ↓ 0.9x
AI Scientist v2
84.40 ± 20.07
52.34 ± 15.56
41.40 ± 1.15 ↑ 1.1x
63.52 ± 2.86 ↑ 1.1x
60.42 ↑ 1.1x
AI Researcher
105.70 ± 21.92 ↑ 1.3x
37.21 ± 5.68 ↓ 0.7x
37.39 ± 0.85
78.80 ± 3.76 ↑ 1.4x
64.78 ↑ 1.1x
Table 1: Solution Quality (SQ, %) ↑ across four discovery tasks and three backbone LLMs. Entries report mean ± std over three seeds; Bold indicates the best result within each backbone.
Figure 4: Best-so-far trajectories across four benchmarks with Qwen3-235B backbone. Across all scientific domains, Triage-PiEvo accumulates high-quality candidates and sustains the highest solution quality.
Model / Method
MBO
NHO
SPO
TMC
Average
APD ↑
AUOC ↑
APD ↑
AUOC ↑
APD ↑
AUOC ↑
APD ↑
AUOC ↑
Avg APD ↑
Avg AUOC ↑
Qwen3-235B (No Thinking)
Vanilla MAS
53.58 ± 15.25
70.09 ± 17.75
32.23 ± 3.72
49.33 ± 17.82
52.03 ± 1.05
36.34 ± 0.38
51.89 ± 3.85
52.67 ± 3.49
47.43
52.11
ReAct
59.43 ± 8.60
70.58 ± 7.95
33.31 ± 1.86
47.46 ± 7.04
56.13 ± 4.49
35.74 ± 0.76
72.93 ± 0.33
66.95 ± 4.67
55.45 ↑ 1.2x
55.18 ↑ 1.1x
AI Scientist v1
52.93 ± 15.22
56.16 ± 26.05
32.98 ± 2.32
38.84 ± 2.06
42.55 ± 5.61
35.62 ± 1.46
64.43 ± 7.02
57.50 ± 6.15
48.22
47.03 ↓ 0.9x
AI Scientist v2
60.26 ± 10.57
76.03 ± 7.92
28.39 ± 3.49
39.51 ± 3.29
48.18 ± 1.41
37.03 ± 0.22
55.66 ± 2.28
54.75 ± 6.66
48.12
51.83
Table 2: Average Pairwise Distance (APD, ↑ ) and Area Under the Optimisation Curve (AUOC, ↑ ) across four tasks and three backbone LLMs. Higher APD indicates broader candidate coverage, while higher AUOC indicates faster accumulation of high-quality candidates.
Figure 5: Cost-efficiency trade-offs across autonomous research harnesses. (a) Token expenditure versus reported Task Score and externally Verified Score. Triage substantially narrows the verification gap (shaded region) with minimal token overhead. (b) Wall-clock execution runtime versus optimization performance across ResearchHarness, AI-Researcher, and Claude Code. Full numerical results are reported in Table 6 (Appendix D ).
Variants
Avg SQ ↑
Avg AUOC ↑
Triage-PiEvo
65.98
60.45
w/o Gate
62.73 ( Δ=−3.25 )
58.23 ( Δ=−2.22 )
Triage-only
60.60 ( Δ=−5.38 )
55.08 ( Δ=−5.37 )
PiEvo ( Pu et al., 2026 )
64.78 ( Δ=−1.20 )
58.15 ( Δ=−2.30 )
Table 3: Module ablations across four tasks. SQ and AUOC are averaged across tasks and seeds.
Appendix figures & tables9 assets
Supplementary material from the paper’s appendix.
Appendix
Constant
Role
Value
τanom
Residual threshold to open diagnostic state
0.85
ϵrep
Same-channel agreement tolerance
0.12
ϵind
Cross-channel agreement tolerance
0.12
τgen
Held-out gain required to authorize a revision
0.16
k
Independent held-out records required for acceptance
2
Appendix
Table 4: Evidence-admission gate hyperparameters. All values are fixed across all experiments.
Figure 6: Gate sensitivity analysis. (a) Missed-mechanism rate as a joint function of the held-out gain threshold τgen and held-out probe attenuation. The default operating point (circle) lies in the zero-error region, and the boundary moves monotonically with effective held-out gain. (b) Verification cost and missed-mechanism rate as a function of the anomaly threshold τanom ; the default (dashed) lies on the flat zero-miss plateau before coverage collapses at more restrictive thresholds.
Figure 7: Performance progression and cost-effectiveness trade-off. (a) Solution Quality (SQ, %) over budget T∈[1,24] . (b) Cost-effectiveness trade-off: Solution Quality versus relative compute and token cost, defining the empirical efficiency frontier.
Figure 8: Execution runtime and discovery throughput across methods. (a) Mean wall-clock runtime per 24-step discovery run across all eight methods under Qwen3-235B. Triage-PiEvo incurs only +13.6% overhead over standard PiEvo due to conditional anomaly-triggered verification, while remaining substantially faster than tree-search or multi-agent debate frameworks (AI Scientist v2, AI Researcher, PiFlow). (b) Scientific exploitation throughput: Exploitation Speed (AUOC, %) versus mean runtime (seconds). Triage-PiEvo achieves the peak discovery throughput, reaching the highest AUOC ( 71.73% ) at competitive execution latency.
Method
Official Score ↑
Target Attainment ↑
Verified Score ↑
Valid Runs (%) ↑
Critical Failure (%) ↓
Cost / Task ()\downarrow$
Claude Code
0.348 ± 0.032
0.312
0.298
78.5%
14.8%
0.84
Codex CLI
0.315 ± 0.041
0.274
0.261
69.2%
22.4%
1.12
AI-Researcher
0.332 ± 0.036
0.295
0.284
74.1%
18.6%
0.68
ResearchHarness
0.286 ± 0.045
0.241
0.230
65.8%
26.2%
0.75
Triage-PiEvo (Ours)
0.418 ± 0.028
0.386
0.382
86.5%
5.2%
0.92
Appendix
Table 5: Performance on AutoResearchEval Optimization Tasks. Comparison of Triage-PiEvo against autonomous scientific and coding agent harnesses across benchmark tasks. Official Score entries show empirical mean ± SD over independent seeds; the other columns report means. Bold indicates the best result.
Harness
Variant
Task Score ↑
Verified Score ↑
False Admission (%) ↓
Revision Accuracy (%) ↑
Token Cost ↓
Runtime (s) ↓
ResearchHarness
Base
0.286
0.230
38.4%
44.2%
14.2k
48.5
+ Self-Review
0.301
0.248
35.2%
48.5%
18.6k
62.1
+ Triage (Ours)
0.345
0.328
14.2%
68.4%
21.4k
71.3
AI-Researcher
Base
0.332
0.284
32.6%
51.8%
16.5k
56.2
+ Self-Review
0.348
0.305
29.8%
56.2%
22.1k
74.8
+ Triage (Ours)
0.389
0.371
11.8%
73.6%
25.8k
86.5
Appendix
Table 6: Triage as a Plug-in across Autonomous Research Harnesses. Incorporating Triage enhances task score and verified reliability while reducing false evidence admissions across the three host architectures.
Table 7: Controlled stress tests under evaluator corruptions and planted mechanisms. Panel A : Across 96 corrupted evaluator and hidden artifact cells, ungated baselines uniformly admit 100% of non-generalizing anomalies into persistent state, whereas Triage-PiEvo achieves 0.0% false admission. Panel B : Across 144 independent planted mechanism trials, Triage-PiEvo successfully recovers 100.0% (144/144) of true mechanisms without confirmation masking.
Method
Exploit Admissions ↓
Exploit Filter
Apparent Proxy
Held-out True
Held-out Gain
(Count / Run)
Rate (%) ↑
Score ↑
Score ↑
Δheldout
Vanilla MAS
4.67 ± 1.15
0.0%
0.812 ± 0.045
0.412 ± 0.061
−0.023± 0.078
ReAct
4.00 ± 0.82
0.0%
0.785 ± 0.038
0.428 ± 0.055
−0.007± 0.073
PiEvo ( Pu et al., 2026 )
5.33 ± 0.58
0.0%
0.894 ± 0.021
0.435 ± 0.048
Baseline
Triage-PiEvo w/o Gate
6.00 ± 0.00
0.0%
0.932 ± 0.015
0.408 ± 0.052
−0.027± 0.071
Triage-PiEvo (Ours)
0.00 ± 0.00
100.0%
0.748 ± 0.029
0.644 ± 0.035
+0.209 ± 0.054
Appendix
Table 8: Robustness against proxy evaluator exploitation. In environments with exploitable surrogate simulator shortcuts, ungated baseline agents repeatedly incorporate deceptive artifacts ( 5.33∼6.00 admissions per run), reporting inflated apparent proxy scores while collapsing on genuine held-out benchmarks. Triage-PiEvo filters 100% of exploit candidates, raising the true held-out score by +0.209±0.054 .
Variant
False Revision (%) ↓
True Mechanism Recall (%) ↑
Verified Score ↑
Retraction Acc. (%) ↑
Verification Cost ()\downarrow$
Full Triage (Ours)
4.8%
92.4%
0.382
93.5%
0.24
k=1 (Permissive Gate)
22.4%
89.2%
0.362
78.5%
0.14
k=3 (Strict Gate)
6.5%
71.8%
0.370
90.8%
0.38
w/o Held-out Verification
34.5%
83.5%
0.315
61.2%
0.18
w/o Channel Reliability
19.2%
81.2%
0.352
76.3%
0.22
w/o Backtracking
16.5%
84.0%
0.338
51.8%
0.21
Appendix
Table 9: Ablation of Evidence Admission Mechanisms. Systematic evaluation of each architectural component in Triage . The full framework achieves the optimal balance between high mechanism recall, high verification accuracy, and low false revision risk.